Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis

Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis

Claudin-2 enhances breast cancer liver metastasis and promotes the development of colorectal cancers. The objective of our current study is to define the regulatory mechanisms controlling Claudin-2 expression in breast cancer cells.

Bibliographic Details
Main Authors: Tabariès, Sébastien, Annis, Matthew G., Hsu, Brian E., Tam, Christine E., Savage, Paul, Park, Morag, Siegel, Peter M.
Format: Online
Language:English
Published: Impact Journals LLC 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496232/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496232/

Similar Items